New Findings from Jinnah Postgraduate Medical Center Update Understanding of Obesity and Diabetes (Efficacy and Safety Profile of Glucagon-like Peptide-1 Receptor Agonist In Obese Type-2 Diabetes Patients From a Private Institution In Karachi).

التفاصيل البيبلوغرافية
العنوان:	New Findings from Jinnah Postgraduate Medical Center Update Understanding of Obesity and Diabetes (Efficacy and Safety Profile of Glucagon-like Peptide-1 Receptor Agonist In Obese Type-2 Diabetes Patients From a Private Institution In Karachi).
المصدر:	Obesity, Fitness & Wellness Week; 9/11/2023, p179-179, 1p
مصطلحات موضوعية:	GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, PEOPLE with diabetes, OBESITY
مصطلحات جغرافية:	KARACHI (Pakistan)
مستخلص:	Karachi, Pakistan, Asia, Bariatrics, Gastrointestinal Hormones, Glucagon, Glucagon-Like Peptide 1, Glucagon-Like Peptides, Health and Medicine, Hormones, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Obesity, Obesity and Diabetes, Peptide Hormones, Peptide Proteins, Peptides, Proglucagon, Proteins, Proteomics, Type 2 Diabetes Keywords: Karachi; Pakistan; Asia; Bariatrics; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Health and Medicine; Hormones; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Obesity; Obesity and Diabetes; Peptide Hormones; Peptide Proteins; Peptides; Proglucagon; Proteins; Proteomics; Type 2 Diabetes EN Karachi Pakistan Asia Bariatrics Gastrointestinal Hormones Glucagon Glucagon-Like Peptide 1 Glucagon-Like Peptides Health and Medicine Hormones Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Obesity Obesity and Diabetes Peptide Hormones Peptide Proteins Peptides Proglucagon Proteins Proteomics Type 2 Diabetes 179 179 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Obesity and Diabetes have been published. For more information on this research see: Efficacy and Safety Profile of Glucagon-like Peptide-1 Receptor Agonist In Obese Type-2 Diabetes Patients From a Private Institution In Karachi. [Extracted from the article]
	Copyright of Obesity, Fitness & Wellness Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات:	Complementary Index

الوصف
تدمد:	15316386